«Oncogenes

Below is an extended Oncogenes patents listing. Click here to return to the Oncogenes main in depth entry.

Patents :
US Patent No.	Title
7410772	Compositions and methods for treatment of non-Hodgkin's lymphoma
7413851	Nucleophosmin directed diagnostics and therapeutics for multidrug resistant neoplastic disease
7413864	Treating cancer using a telomerase vaccine
7413866	Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
7413870	SAK: modulation of cellular proliferation for treatment of cancer
7413876	Expression of G protein coupled receptors in yeast
7413897	Primitive and proximal hepatic stem cells
7413899	Genes from the 20q13 amplicon and their uses
7413904	Human embryonic stem cells having genetic modifications
7414026	Inhibitors of NF-kappaB activation
7414035	hKIS composition and methods of use
7413734	Treatment of retinitis pigmentosa with human umbilical cord cells
7413733	Antigen transduced T cells used as a delivery system for antigens
7413712	Microfluidic rotary flow reactor matrix
7410954	Adenovirus serotype 30 (Ad30)
7410975	Small molecule toll-like receptor (TLR) antagonists
7410988	2-Amido-thiazole-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof
7411037	Polypeptides encoded by a nucleic acid underexpressed in melanoma
7411042	Tumor associated nucleic acids and uses therefor
7411043	Slo4 potassium channel proteins
7411050	Monoclonal blocking antibody to human RANKL
7411051	Antibodies to HDPPA04 polypeptide
7411055	Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof
7412333	Method for prognostic factor analysis regarding cancers
7414121	Chimeric, human and humanized anti-CSAp monoclonal antibodies
7414169	Therapeutic and diagnostic tools for impaired glucose tolerance conditions
7419791	Methods of screening compounds using a T1R3 hetero-oligomeric taste receptor
7419808	Methods and compositions for the production of adenoviral vectors
7419826	Human schwannoma cell line
7419827	Cell lines
7419828	Compositions and methods for non-targeted activation of endogenous genes
7419829	Vector system
7419948	Treatment of hemophilia with human Factor IX produced in mammary tissue of transgenic mammals
7419988	Azaindole inhibitors of aurora kinases
7419995	N-substituted benzimidazoyl c-Kit inhibitors and combinatorial benzimidazole library
7420044	Nucleic acid and protein homologs and uses thereof
7419785	Methods and compositions in breast cancer diagnosis and therapeutics
7419779	Modulators of angiogenesis
7419777	Method and quantification assay for determining c-kit/SCF/pAKT status
7415358	Molecular toxicology modeling
7415359	Methods and systems for the identification of components of mammalian biochemical networks as targets for therapeutic agents
7416728	Growth blocking agents
7416885	Proliferated cell lines and uses thereof
7416888	Cell lines
7417026	Mobilization of hematopoietic cells
7417055	Kinase inhibitory phosphonate analogs
7417113	PSCA: prostate stem cell antigen and uses thereof
7417121	Human G-protein coupled receptor, HGPRBMY39
7417125	Antibodies that bind a PRO1158 polypeptide
7420045	IAPs associated cell cycle proteins, compositions and methods of use

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.